× Medicines Discovery Catapult

Mark was previously the founding MD of the National Institute for Health Research Office for Clinical Research Infrastructure (NOCRI) and a founder member of the NIHR Strategy Board. The NIHR is responsible for clinical research in the NHS across England, with an annual budget of over £1bn.

Mark established the NOCRI office in Whitehall, working in close collaboration with the Department of Health. He worked with 10 Downing Street to contribute to the Prime Minister’s Strategy for UK Life Sciences. He frequently represented the NIHR in the media.

Mark originally worked in industry. Representing the UK diagnostics industry, he co-chaired with Sir Andrew Dillon the Evaluation Pathway programme, which established a way for NICE to evaluate medical devices and diagnostics.

Mark was educated at Queen Mary University of London and Oxford’s Saïd Business School. He also holds a Policy Fellowship at Cambridge University. He has completed the Leading Economic Growth programme at Harvard and written in the national press about how science contributes to national competitiveness.

Related Articles